EUVIMEDEUVIMED entdecken
Crossref

Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide

Huiqing Yuan, Xiaoshan Chen, Mengmeng Zhao, Xinming Zhao iD, Xiaolin Chen, Jingya Han, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Meng Dai, Yunuan Liu

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2024.0073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Huiqing Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Gallium Radioisotopes, Radiopharmaceuticals, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: [ 68 Ga]Ga-DOTA-FGFR1-peptide is a novel positron emission tomography (PET) radiotracer targeting fibroblast growth factor receptor 1 (FGFR1). This study evaluated the safety, biodistribution, radiation dosimetry, and imaging potential of [ 68 Ga]Ga-DOTA-FGFR1-peptide.

Methods

The FGFR1-targeting peptide DOTA-(PEG2)-KAEWKSLGEEAWHSK was synthesized by manual solid-phase peptide synthesis with high-performance liquid chromatography purification, and labeled with 68 Ga with DOTA as chelating agent. We recruited 14 participants and calculated the radiation dose of 4 of these pathologically confirmed nontumor subjects using OLINDA/EXM 2.2.0 software. At the same time, the imaging potential in 10 of these lung cancer patients was evaluated.

Results

The biodistribution of [ 68 Ga]Ga-DOTA-FGFR1-peptide in 4 subjects showed the highest uptake in the bladder and kidney. Dosimetry analysis indicated that the bladder wall received the highest effective dose (3.73E-02 mSv/MBq), followed by the lungs (2.36E-03 mSv/MBq) and red bone marrow (2.09E-03 mSv/MBq). No normal organs were found to have excess specific absorbed doses. The average systemic effective dose was 4.97E-02 mSv/MBq. The primary and metastatic tumor lesions were clearly visible on PET/computed tomography (CT) images in 10 patients.

Conclusion

Our results indicate that [ 68 Ga]Ga-DOTA-FGFR1-peptide has a good dosimetry profile and can be used safely in humans, and it has significant potential value for clinical PET/CT imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1Gallium RadioisotopesRadiopharmaceuticalsLung NeoplasmsRadiometryHumansTissue DistributionMaleFemaleMiddle AgedAgedPositron Emission Tomography Computed TomographyAdultOrganometallic CompoundsHeterocyclic Compounds, 1-Ring

Stichwörter der Autor:innen

FGFR1FGFR1-positive tumorPET/CTbiodistributiondosimetry

Substanzen

Receptor, Fibroblast Growth Factor, Type 1Gallium RadioisotopesRadiopharmaceuticalsFGFR1 protein, humanOrganometallic CompoundsHeterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, China.

ORCID-Profile: Xinming Zhao

Zitieren

APA

Yuan, H., Chen, X., Zhao, M., Zhao, X., Chen, X., Han, J., Zhang, Z., Zhang, J., Wang, J., Dai, M., & Liu, Y. (2024). Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0073

Vancouver

Yuan H, Chen X, Zhao M, Zhao X, Chen X, Han J, et al. Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2024.0073

BibTeX
@article{Yuan2024,
  author = {Yuan, Huiqing and Chen, Xiaoshan and Zhao, Mengmeng and Zhao, Xinming and Chen, Xiaolin and Han, Jingya and Zhang, Zhaoqi and Zhang, Jingmian and Wang, Jianfang and Dai, Meng and Liu, Yunuan},
  title = {Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2024.0073}
}
Kostenlos starten →